Showing 17,721 - 17,740 results of 31,582 for search '(( 50 ((((we decrease) OR (a decrease))) OR (nn decrease)) ) OR ( a step decrease ))', query time: 0.76s Refine Results
  1. 17721
  2. 17722

    DataSheet_1_Identifying hub genes in response to ustekinumab and the impact of ustekinumab treatment on fibrosis in Crohn’s disease.zip by Ying Xu (9172)

    Published 2024
    “…Introduction<p>Crohn’s disease (CD) is a chronic inflammatory disease. Approximately 50% of patients with CD progressed from inflammation to fibrosis. …”
  3. 17723

    Table_1_Narrowing row spacing and adding inter-block promote the grain filling and flag leaf photosynthetic rate of wheat under enlarged drip tube spacing system.xlsx by Jianguo Jing (18767383)

    Published 2024
    “…The decline of NS22 (9.93%) was higher than that of NS44 (9.04%), and both cultivars also showed a greater decrease in grain weight and average grain-filling rate (AGFR) of inferior grains (NS22: 23.19%, 13.97%; NS44: 7.78%, 5.86%) than the superior grains (NS22: 10.60%, 8.33%; NS44: 4.89%, 4.62%). …”
  4. 17724

    DataSheet_1_Narrowing row spacing and adding inter-block promote the grain filling and flag leaf photosynthetic rate of wheat under enlarged drip tube spacing system.zip by Jianguo Jing (18767383)

    Published 2024
    “…The decline of NS22 (9.93%) was higher than that of NS44 (9.04%), and both cultivars also showed a greater decrease in grain weight and average grain-filling rate (AGFR) of inferior grains (NS22: 23.19%, 13.97%; NS44: 7.78%, 5.86%) than the superior grains (NS22: 10.60%, 8.33%; NS44: 4.89%, 4.62%). …”
  5. 17725

    Image1_Total flavonoids extracted from Penthorum chinense Pursh mitigates CCl4-induced hepatic fibrosis in rats via inactivation of TLR4-MyD88-mediated NF-κB pathways and regulatio... by Sujuan Wang (1865149)

    Published 2023
    “…Subsequently, rats were randomly assigned to a control group (Control), a carbon tetrachloride (CCl<sub>4</sub>)-induced hepatic fibrosis model group (Model), a positive control group [0.2 mg/(kg∙day)] of Colchicine), and three TFPCP treatment groups [50, 100, and 150 mg/(kg∙day)]. …”
  6. 17726

    Image2_Total flavonoids extracted from Penthorum chinense Pursh mitigates CCl4-induced hepatic fibrosis in rats via inactivation of TLR4-MyD88-mediated NF-κB pathways and regulatio... by Sujuan Wang (1865149)

    Published 2023
    “…Subsequently, rats were randomly assigned to a control group (Control), a carbon tetrachloride (CCl<sub>4</sub>)-induced hepatic fibrosis model group (Model), a positive control group [0.2 mg/(kg∙day)] of Colchicine), and three TFPCP treatment groups [50, 100, and 150 mg/(kg∙day)]. …”
  7. 17727

    Image_1_Archetypal type II and III Toxoplasma gondii oocysts induce different immune responses and clinical outcomes in experimentally infected piglets.tif by Andrea Largo-de la Torre (13985607)

    Published 2022
    “…Apathy and a moderate decrease in feed consumption were observed in G1 and G2 piglets between 5 and 8 dpi, coinciding with fever (>40°C). …”
  8. 17728

    Ongoing LFP activity in V1 and subiculum during continuous change of anesthesia level. by Rüdiger Land (297646)

    Published 2013
    “…<p>(A) Reconstruction of electrode site location. Upper electrode sites are located in V1 (gray dots) and lower sites in subiculum (white dots). …”
  9. 17729

    cbVG-dependent SGs are not required for the antiviral response during RSV cbVG-high infection. by Lavinia J. González Aparicio (17420047)

    Published 2023
    “…<p>mRNA copy numbers of (<b>A</b>) <i>IL29</i>, (<b>B</b>) <i>ISG56</i>, and (<b>C</b>) <i>IRF7</i> relative to the HKI in A549 control, G3BP1 KO, G3BP2 KO, and G3BP1/2 dKO cells 24 hpi with RSV cbVG-high at MOI 1.5 TCID<sub>50</sub>/cell. …”
  10. 17730

    Modulation of AChR and GABA<sub>R</sub> can restore post-synaptic folding. by M. Catarina Silva (189975)

    Published 2013
    “…(B) L-AChR activation with the agonist levamisole (in water) suppressed Q35 aggregation at 5 µM, but enhanced aggregation at 50 µM. Mutant AChR <i>unc-38(e264)</i> is a control for AChR-mediated effect. …”
  11. 17731

    Prostaglandin E2 potentiation of P2X3 receptor mediated currents in dorsal root ganglion neurons-5 by Congying Wang (81505)

    Published 2011
    “…</p><p></p>β-meATP (1 nmol/50 μl) or PGE2 ((0.05 nmol/50 μl). The data were normalized with baseline responses before either injection. α,β-meATP and PGE2 applied individually resulted in a moderate decrease in the threshold [(1-meATP/Con) = 0.22 ± 0.04; (1-PGE/Con) = 0.16 ± 0.03, n = 3)]. …”
  12. 17732

    No inhibition of TrxR1 activity <i>in vitro</i> by addition of SecTRAPs by Karin Anestål (377878)

    Published 2013
    “…The turnover (min<sup>−1</sup>) is calculated from the decrease at 340 nm detected in a microplate reader assay using 5 nM TrxR1, 145 µM insulin in 50 mM Tris-Cl, 2 mM EDTA, pH 7.4 and 200 µM NADPH.…”
  13. 17733

    GDF11 inhibits Cyclin D2 expression. by Gareth Williams (5148)

    Published 2013
    “…(<b>B</b>) Densitometric analysis of western blots of lysates from Cor-1 cells treated with 25 or 50 ng/ml of GDF11 for 24 hr shows a significant decrease in Cyclin D2 protein levels (mean ± SEM; **<i>p</i><0.01, n = 3). …”
  14. 17734

    PDTC inhibits the <i>Nacrein</i> promoter activity. by Juan Sun (439334)

    Published 2015
    “…Increasing amounts of PDTC lead to a decrease in luciferase activity, suggesting a decrease in <i>Nacrein</i> promoter activity. …”
  15. 17735
  16. 17736
  17. 17737
  18. 17738
  19. 17739
  20. 17740